2020
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.
Böhm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Konstantinidis D, Choi JW, East C, Lee DP, Ma A, Ewen S, Cohen DL, Wilensky R, Devireddy CM, Lea J, Schmid A, Weil J, Agdirlioglu T, Reedus D, Jefferson BK, Reyes D, D'Souza R, Sharp ASP, Sharif F, Fahy M, DeBruin V, Cohen SA, Brar S, Townsend RR, SPYRAL HTN-OFF MED Pivotal Investigators. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet 2020, 395: 1444-1451. PMID: 32234534, DOI: 10.1016/S0140-6736(20)30554-7.Peer-Reviewed Original Research
2019
A BALLOONING CARDIOVASCULAR CONDITION: REVASCULARIZATION IN A PATIENT WITH KAWASAKI DISEASE AND CORONARY ARTERY ANEURYSMS
Upadhyaya K, Remetz M. A BALLOONING CARDIOVASCULAR CONDITION: REVASCULARIZATION IN A PATIENT WITH KAWASAKI DISEASE AND CORONARY ARTERY ANEURYSMS. Journal Of The American College Of Cardiology 2019, 73: 2431. DOI: 10.1016/s0735-1097(19)33037-2.Peer-Reviewed Original Research
2015
Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia.
Vierthaler L, Callas PW, Goodney PP, Schanzer A, Patel VI, Cronenwett J, Bertges DJ, Vascular Study Group of New England. Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia. J Vasc Surg 2015, 62: 655-64.e8. PMID: 26215708, DOI: 10.1016/j.jvs.2015.04.391.Peer-Reviewed Original ResearchTrial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease
Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E, Zeller T, Krishnan P, Gammon R, Müller-Hülsbeck S, Nehler MR, Benenati JF, Scheinert D. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. New England Journal Of Medicine 2015, 373: 145-153. PMID: 26106946, DOI: 10.1056/nejmoa1406235.Peer-Reviewed Original ResearchConceptsDrug-coated balloonsPaclitaxel-coated balloonPeripheral artery diseasePercutaneous transluminal angioplastyPrimary patencyArtery diseaseTransluminal angioplastyStandard angioplastyStandard balloonSymptomatic femoropopliteal peripheral artery diseaseFemoropopliteal peripheral artery diseasePrimary efficacy end pointPrimary safety end pointEnd pointSignificant between-group differencesComposite of freedomPrimary safety eventsSymptomatic intermittent claudicationEfficacy end pointSafety end pointFemoropopliteal artery diseaseProportion of patientsSignificant atherosclerotic lesionsBetween-group differencesRate of death
2000
Perceptions of Benefit and Risk of Patients Undergoing First‐time Elective Percutaneous Coronary Revascularization
Holmboe E, Fiellin D, Cusanelli E, Remetz M, Krumholz H. Perceptions of Benefit and Risk of Patients Undergoing First‐time Elective Percutaneous Coronary Revascularization. Journal Of General Internal Medicine 2000, 15: 632-637. PMID: 11029677, PMCID: PMC1495592, DOI: 10.1046/j.1525-1497.2000.90823.x.Peer-Reviewed Original ResearchConceptsElective percutaneous coronary revascularizationPercutaneous coronary revascularizationMajority of patientsCoronary revascularizationAbnormal diagnostic test resultsFuture myocardial infarctionRelief of symptomsRisk of patientsDiagnostic test resultsConsecutive patientsMean ageMyocardial infarctionLong-term benefitsPossible complicationsPotential complicationsPatient decisionPatient expectationsPatientsSemistructured questionnaireRevascularizationComplicationsRiskPerceptions of benefitsPotential riskQuestionnaire
1998
CARDIOVASCULAR MANIFESTATIONS OF SYSTEMIC AUTOIMMUNE DISEASES
Longo M, Remetz M. CARDIOVASCULAR MANIFESTATIONS OF SYSTEMIC AUTOIMMUNE DISEASES. Clinics In Chest Medicine 1998, 19: 793-808. PMID: 9917967, DOI: 10.1016/s0272-5231(05)70117-9.Peer-Reviewed Original ResearchConceptsSystemic autoimmune diseaseAutoimmune diseasesCardiovascular manifestationsSerious life-threatening conditionLife-threatening conditionAsymptomatic abnormalitiesClinical consequencesClinical pathophysiologyProtean groupCardiovascular systemConnective tissueDiseaseManifestationsPathophysiologyIllnessAbnormalitiesModulation of Circulating Cellular Adhesion Molecules in Postmenopausal Women With Coronary Artery Disease
Caulin-Glaser T, Farrell W, Pfau S, Zaret B, Bunger K, Setaro J, Brennan J, Bender J, Cleman M, Cabin H, Remetz M. Modulation of Circulating Cellular Adhesion Molecules in Postmenopausal Women With Coronary Artery Disease. Journal Of The American College Of Cardiology 1998, 31: 1555-1560. PMID: 9626834, DOI: 10.1016/s0735-1097(98)00145-4.Peer-Reviewed Original ResearchConceptsE2 replacement therapyCoronary artery diseaseVascular cell adhesion molecule-1Cellular adhesion moleculesPostmenopausal womenAdhesion molecule-1Premenopausal womenArtery diseaseCardioprotective effectsInflammatory responseAdhesion moleculesMolecule-1Incidence of CADControl groupInflammatory cytokine-induced expressionIntercellular adhesion molecule-1Expression of CAMsCell adhesion molecule-1Consecutive eligible subjectsAssociation of estrogenEndothelial cell activationCytokine-induced expressionFemale control groupSignificant increaseEnzyme-linked immunoabsorbant assay
1994
Comparison of symptoms, functional ability, and health perception of elderly patients with coronary artery disease managed with three different treatment modalities.
Vogt AR, Funk M, Remetz M. Comparison of symptoms, functional ability, and health perception of elderly patients with coronary artery disease managed with three different treatment modalities. Cardiovasc Nurs 1994, 30: 33-8. PMID: 7882409.Peer-Reviewed Original ResearchEffects of altered left ventricular geometry on quantitative technetium 99m sestamibi defect size in humans: Perfusion imaging during coronary angioplasty
Haronian H, Sinusas A, Remetz M, Brennan J, Cabin H, Zaret B, Wackers F. Effects of altered left ventricular geometry on quantitative technetium 99m sestamibi defect size in humans: Perfusion imaging during coronary angioplasty. Journal Of Nuclear Cardiology 1994, 1: 150-158. PMID: 9420682, DOI: 10.1007/bf02984087.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyLeft ventricular geometryAltered left ventricular geometryCoronary angioplastyRegional wall motionVentricular geometryEnd-diastolic imagesMyocardial perfusionExercise-induced myocardial ischemiaAbnormal regional wall motionMyocardial risk areaTransluminal coronary angioplastyQuantitative defectsExperimental animal modelsPlanar myocardial perfusionMyocardial perfusion imagingQuantitative technetiumResultsNine patientsVentricular functionCoronary arteryMyocardial infarctionVessel occlusionMyocardial ischemiaPerfusion defectsWall motionPredictors of Coronary Dissection following Percutaneous Transluminal Coronary Balloon Angioplasty
Ilia R, Bigham H, Brennan J, Cabin H, Cleman M, Remetz M. Predictors of Coronary Dissection following Percutaneous Transluminal Coronary Balloon Angioplasty. Cardiology 1994, 85: 229-234. PMID: 7987880, DOI: 10.1159/000176680.Peer-Reviewed Original ResearchConceptsCoronary dissectionLong lesionsPercutaneous transluminal coronary balloon angioplastyNon-Q-wave myocardial infarctionAcute coronary dissectionCoronary balloon angioplastyConsecutive patientsCoronary angioplastyBalloon dilatationFemale patientsArterial dilatationBalloon angioplastyMyocardial infarctionMost dissectionsPatientsMore dissectionAngioplastyDissectionLesionsComplicationsArteryDilatationPredictorsInfarctionWomen
1993
Myocardial risk area defined by technetium-99m sestamibi imaging during percutaneous transluminal coronary angioplasty: Comparison with coronary angiography
Haronian H, Remetz M, Sinusas A, Baron J, Miller H, Cleman M, Zaret B, Wackers F. Myocardial risk area defined by technetium-99m sestamibi imaging during percutaneous transluminal coronary angioplasty: Comparison with coronary angiography. Journal Of The American College Of Cardiology 1993, 22: 1033-1043. PMID: 8409038, DOI: 10.1016/0735-1097(93)90413-u.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAngioplasty, Balloon, CoronaryClinical ProtocolsCollateral CirculationCoronary AngiographyCoronary DiseaseEvaluation Studies as TopicFemaleHumansMaleMiddle AgedMyocardial InfarctionObserver VariationPredictive Value of TestsPrognosisReproducibility of ResultsRisk FactorsSeverity of Illness IndexTechnetium Tc 99m SestamibiTomography, Emission-Computed, Single-PhotonConceptsMyocardial risk areaCoronary angiographyCoronary angioplastyQuantitative myocardial perfusionMyocardial perfusionMyocardial areaPercutaneous transluminal coronary angioplastyAngiographic risk scoresSmall risk areasTransluminal coronary angioplastyCoronary artery diseaseCoronary artery stenosisInitial myocardial uptakeAngioplasty balloon inflationArtery diseaseLeft anteriorNonperfused areaArtery stenosisCoronary anatomyCoronary arteryBalloon inflationPatient managementMyocardial uptakeRisk scoreAngioplastyClinical and Angiographic Determinants of Initial Percutaneous Transluminal Coronary Angioplasty Success
Ilia R, Kolanski D, Setaro J, Brennan J, Cabin H, Cleman M, Remetz M. Clinical and Angiographic Determinants of Initial Percutaneous Transluminal Coronary Angioplasty Success. Angiology 1993, 44: 677-682. PMID: 8357092, DOI: 10.1177/000331979304400901.Peer-Reviewed Original ResearchConceptsCoronary angioplastyPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyAcute myocardial infarctionSuccess rateDegree of stenosisLong-term pretreatmentAngiographic determinantsAngioplasty successPostinfarction anginaAngiographic characteristicsSuccessful angioplastyClinical featuresMyocardial infarctionAnatomic determinantsPrimary successAngioplastyPatientsSuccessful procedureAspirinBeneficial effectsLesionsHigh rateAdditional findingsAnginaCoronary angioplasty with gradual versus rapid balloon inflation: Initial results and complications
Ilia R, Cabin H, McConnell S, Cleman M, Remetz M. Coronary angioplasty with gradual versus rapid balloon inflation: Initial results and complications. Catheterization And Cardiovascular Interventions 1993, 29: 199-202. PMID: 8402842, DOI: 10.1002/ccd.1810290305.Peer-Reviewed Original ResearchConceptsInflation protocolFrequency of dissectionLesion morphological characteristicsRapid balloon inflationProcedure-related complicationsComplete success rateSuccess rateGradual inflationUnstable anginaComplication rateCoronary angioplastySignificant group differencesArterial damageBalloon inflationDissection rateHigh success rateDiseased vesselsMore lesionsPatientsLesionsInflation groupGroup differencesAngioplastyComplicationsVessel diameter ratio
1992
Characteristics of cigarette smokers versus nonsmokers in patients referred for coronary angioplasty
Ilia R, Brennan J, Cabin H, Cleman M, Remetz M. Characteristics of cigarette smokers versus nonsmokers in patients referred for coronary angioplasty. Coronary Artery Disease 1992, 3: 859-862. DOI: 10.1097/00019501-199209000-00013.Peer-Reviewed Original ResearchPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyCoronary angioplastyCoronary dissectionSuccess rateConsecutive patientsMajor complicationsCigarette smokersTotal occlusionLong lesionsAngioplastySmokersConsecutive lesionsPatientsLesionsNonsmokersDissectionComplicationsGroupOcclusionCardiovascular manifestations of connective tissue disorders
Remetz M, Matthay R. Cardiovascular manifestations of connective tissue disorders. Journal Of Thoracic Imaging 1992, 7: 49-63. PMID: 1501267, DOI: 10.1097/00005382-199206000-00006.Peer-Reviewed Original ResearchConceptsConnective tissue disordersTissue disordersImportant pathophysiologic processConnective tissue diseaseConnective tissue supportVascular manifestationsCardiovascular manifestationsTissue diseaseAcquired formsPathophysiologic processesCardiovascular performanceDisease processCardiovascular pathologyCollagen disordersVascular structuresConnective tissueTissue supportDisordersManifestationsVascular elementsIntegral roleTissueCardiac evaluation
Remetz M, Matthay R. Cardiac evaluation. Disease-a-Month 1992, 38: 338-503. PMID: 1591964, DOI: 10.1016/0011-5029(92)90017-j.Peer-Reviewed Original ResearchConceptsCardiac evaluationDiagnostic testsEfficient diagnostic planExercise treadmill testingCardiac diagnostic testsRadionuclide imaging techniquesSpecific diagnostic testsMagnetic resonance imagingBasic diagnostic toolCardiac catheterizationTreadmill testingPhysical examCardiac patientsCardiovascular diseaseChest radiographsDiagnostic modalitiesCardiac diseaseClinical examNew imaging modalityResonance imagingDiagnostic planDisease statesCardiac imagingImaging modalitiesPatientsLong-term outcome in patients with congestive heart failure and intact systolic left ventricular performance
Setaro J, Soufer R, Remetz M, Perlmutter R, Zaret B. Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. The American Journal Of Cardiology 1992, 69: 1212-1216. PMID: 1575193, DOI: 10.1016/0002-9149(92)90938-u.Peer-Reviewed Original ResearchConceptsCongestive heart failureLV systolic functionLV ejection fractionLong-term outcomesThird heart soundCardiovascular eventsCardiovascular mortalitySystolic functionEjection fractionHeart failurePulmonary edemaAverage LV ejection fractionRecurrent congestive heart failureNormal LV systolic functionLeft ventricular systolic performanceSame favorable prognosisLV diastolic dysfunctionAcute pulmonary edemaFuture cardiovascular eventsHypertensive heart diseaseVentricular systolic performanceCoronary artery diseaseHeart soundNoncardiovascular mortalityCardiovascular morbidityThe Right Ventricle in Disorders Causing Pulmonary Venous Hypertension
Setaro J, Cleman M, Remetz M. The Right Ventricle in Disorders Causing Pulmonary Venous Hypertension. Cardiology Clinics 1992, 10: 165-183. PMID: 1739957, DOI: 10.1016/s0733-8651(18)30261-3.Peer-Reviewed Original ResearchConceptsPulmonary venous hypertensionRight ventricular functionRight ventricleVenous hypertensionVentricular functionLeft-sided heart lesionsLeft-sided heart failurePulmonary arterial hypertensionCharacteristic clinical findingsPulmonary arterial systemImportant prognostic informationObstructive originArterial hypertensionHeart failureHemodynamic adaptationClinical findingsHeart lesionsPulmonary veinsPrognostic informationInterventricular septumHypertensionChronic compensationLeft ventricleVentricleArterial systemEndovascular Infections Arising from Right-Sided Heart Structures
Remetz M, Quagliarello V. Endovascular Infections Arising from Right-Sided Heart Structures. Cardiology Clinics 1992, 10: 137-149. PMID: 1739955, DOI: 10.1016/s0733-8651(18)30259-5.Peer-Reviewed Original ResearchConceptsRight-sided endocarditisRight-sided heart failureLeft-sided endocarditisAntibiotic therapyHeart failureClinical manifestationsWorse prognosisTricuspid valveEndovascular infectionProgressive right-sided heart failureS. aureusMultiple septic pulmonary emboliSeptic pulmonary emboliInitial antibiotic therapyCombination antibiotic therapyCommon predisposing factorsCases of endocarditisCongenital heart diseaseViridans group streptococciCoexistent infectionPleuritic painProductive coughSignificant murmurPulmonary infarctionCardiac manifestationsPreface
Remetz M, Cabin H. Preface. Cardiology Clinics 1992, 10: xiii-xv. DOI: 10.1016/s0733-8651(18)30251-0.Peer-Reviewed Original Research